Lingying Wu

ORCID: 0000-0003-3153-7786 · 5 papers in corpus
diagnostic-accuracy 2022
BMC cancer ·doi:10.1186/s12885-022-10138-w

BACKGROUND: CircN4BP2L2 was previously identified to be significantly decreased in epithelial ovarian cancer (EOC) and was associated with disease progression. The aim of this study was to evaluate the diagnostic value of plasma circN4BP2L2…

diagnostic-accuracy 2022
BMC cancer ·doi:10.1186/s12885-021-09073-z

BACKGROUND: Circular RNAs (circRNAs) are more stable than linear RNA molecules, which makes them promising diagnostic biomarkers for diseases. By circRNA-sequencing analysis, we previously found that circN4BP2L2 was significantly decreased …

observational 2020
American journal of cancer research

This retrospective cohort study was designed to explore the prognostic impact of adjuvant chemotherapy and tumor substage on stage I ovarian clear cell carcinoma (OCCC). Data of 102 patients with stage I OCCC who underwent surgery at the Na…

observational 2019
·doi:10.1200/jco.2019.37.15_suppl.e17090

e17090 Background: Ovarian clear cell carcinoma is one kind of Epithelial ovarian carcinoma and is considered high-grade tumor. This retrospective analysis aimed to evaluate the clinical and pathologic features and to determine prognostic v…

rct 2005
Zhonghua fu chan ke za zhi

OBJECTIVE: To investigate serum CA(125) levels and the value of serum CA(125) in differential diagnosis of benign pelvic mass. METHODS: We retrospectively analyzed 492 patients with benign pelvic mass, including 237 cases of benign ovarian…